Pittsburgh bioidentical hormones expert, Keith Wharton, M.D. discusses how bioidentical hormone therapy could help women who have undergone surgical menopause.
Women would only be a candidate for estrogen-only bioidentical hormone replacement therapy (BHRT) if they have undergone a hysterectomy; otherwise there is a significant risk of uterine cancer. However, in women who have had a hysterectomy, estrogen will provide protection from osteoporosis, decrease the risk of colon cancer and provide cardiac protection from heart attack. Additionally, estrogen will enhance the quality of sleep. It will decrease the mental fog experienced by menopause. It will help with dry skin and some patients notice less dry eyes and vaginal dryness.
There are estrogen receptors in the urethra and lower bladder. So Estrogen reduces the risk of bladder infections and helps with overactive bladder and urinary incontinence in postmenopausal women. Also, intimacy issues can improve as vaginal dryness is eliminated.
The best time to start taking an estrogen regimen is within the first 3 years of menopause. This gives better bone and cardiac protection because it is taken for a longer period of time. It is best to start immediately rather than waiting for a problem to develop.
For more information, read: Hysterectomy and Bioidentical Hormones
About Dr. Wharton
Dr. Keith Wharton received his undergraduate from West Virginia University in 1976. After completing his Doctorate at Marshall University School of Medicine in 1981, Dr. Wharton went on to fulfill his Residency in Obstetrics and Gynecology at the State University of New York, where he received the Vincent Capraro Award for Academic and Clinical Excellence in 1985. Dr. Wharton served as President of the Pittsburgh Obstetrical and Gynecological Society from 2007-2008 and is an active member in several professional organizations and medical societies, including the American College of Obstetrics and Gynecology, the Pennsylvania Medical Society and the Allegheny County Medical Society.